About the program
In 2012, Bayer launched the Global Ophthalmology Awards Program (GOAP) with the aim of advancing the scientific understanding and clinical management of retinal ophthalmic disorders. Through grants supporting research and training in ophthalmology, the program seeks to provide opportunities for treatment improvement and to encourage ophthalmologists to further develop their skills in the management of retinal disorders.
Who Are We?
Bayer envisions the GOAP as a step towards making the dream of ophthalmology cures and improved treatments a reality.
The GOAP demonstrates our commitment to the global ophthalmic disorders community and to advancing state-of-the-art ophthalmic care.